As an Accutane victim, what chance do you have of recovering your financial losses for medical bills, lost wages and pain and suffering? It turns out you have a solid chance, in that Accutane lawsuits already are prevailing for victims in America’s courts.
So far more than 5,000 such Accutane lawsuits have been filed, and several have been tried. In those, juries have found in favor of victims once it became clear that Roche Pharmaceuticals, the acne drug’s Swiss-based manufacturer, was aware of its acne medication’s dangers yet failed to warn prospective users sufficiently.
As a result, many of Accutane’s 13 millions users worldwide, and five million in America, have been afflicted with serious inflammatory bowel disease (IBD) injuries such as Crohn’s disease and ulcerative colitis. Each of these Accutane side effects is lifelong, incurable and debilitating, which makes an Accutane lawsuit to recover damages necessary.
Already, one Alabama man has been awarded $25 million in his Accutane lawsuit after having to have his colon removed due to injuries caused by the defective drug. In fact, juries have awarded a total of $56 million to victims so far in just a handful of Accutane lawsuits. And Roche certainly has the money to pay, since it’s earned billions of dollars selling its defective drug to unsuspecting consumers.
To launch the process of pursuing such justice, simply alert the experienced attorneys of Accutane-Lawsuit-Lawyer.com. By submitting the online free case review or by calling 1-800-339-0606, you can be aligned with an Accutane lawyer for your state.
Let the legal team of Accutane-Lawsuit-Lawyer.com go to work for you and start seeking the economic recovery and sense of justice you deserve after enduring such a serious Accutane side effect as Crohn’s disease or ulcerative colitis -- conditions which often mandate surgically removing all or part of the colon.
Such harm caused by a negligent manufacturer should not go unchallenged. Alert Accutane-Lawsuit-Lawyer.com today, and put your challenge in motion.